Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop ...

Life sciences organizations face challenges spanning culture, leadership, infrastructure, and skills to implement FAIR data ...

The N=1 frontier isnt just about helping the rarest patients, its about building the infrastructure for medicines future, write experts at Uncommon Cures.

On this week's Business Of Biotech episode, Atul Deshpande, Ph.D., CEO at Immediate Therapeutics, talks about partnering with American cities to conduct clinical trials during ambulance rides to the ...

On this week's Business Of Biotech episode, Milan Kalawadia, CEO, North America, Dr. Reddy's Laboratories, and Arun Swaminathan, Ph.D., CEO, Coya Therapeutics discuss their unique partnership to ...

On this week's episode, ex-handballer Vladimir Cmiljanovic, Ph.D., Founder and CEO at Swiss Rockets, talks about co-discovering bimiralisib with his sister Natasa Cmiljanovic, Ph.D. (and COO at Swiss ...

Between the miles of carpeted conference halls I've walked (my step counter stopped caring after Dallas), the countless cups of mediocre conference coffee, and enough airplane peanuts to feed a small ...

This is Episode 4 of "FDA Fridays," a special series from Cell & Gene: The Podcast, Chief Editor Erin Harris speaks with regulatory affairs expert Daniela Drago, Partner, NDA Partners, about how ...

Oncology clinical trials are among the most complex and demanding in the medical research landscape, often characterized by extended timelines and low success rates. In 2022, a mere 3.5% of these ...

EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator to improve access for trial participants. DENVER, Colo., Aug. 25, 2025 – PCM Trials, along ...